ribavirin has been researched along with taribavirin in 51 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (7.84) | 18.7374 |
| 1990's | 2 (3.92) | 18.2507 |
| 2000's | 35 (68.63) | 29.6817 |
| 2010's | 9 (17.65) | 24.3611 |
| 2020's | 1 (1.96) | 2.80 |
| Authors | Studies |
|---|---|
| Crippen, GM; Ghose, AK; McKernan, PA; Revankar, GR; Robins, RK; Smee, DF | 1 |
| Barthel-Rosa, L; Chmurny, GN; Gabrielsen, B; Huggins, JW; Kefauver, DF; Monath, TP; Phelan, MJ; Schubert, EM; See, C; Ussery, MA | 1 |
| Avery, TL; Kini, GD; Robins, RK | 1 |
| Barnard, DL; Huffman, JH; Pifat, DY; Sidwell, RW | 1 |
| Robins, RK; Seegmiller, JE; Willis, RC | 1 |
| Barnett, BB; Gilbert, J; Huggins, JH; Leonhardt, JA; Sidwell, RW; Smee, DF | 1 |
| Bergstrom, DE; Davisson, VJ; Klewer, DA; LiWang, AC; Zhang, P | 1 |
| Watson, J | 1 |
| Barnard, D | 1 |
| Hong, Z; Lau, JY; Walker, H; Wu, JZ | 1 |
| Lin, CC; Lourenco, D; Luu, K; Yeh, LT | 1 |
| Hong, Z; Lin, CC; Wu, JZ | 1 |
| Hong, Z; Lin, CC; Vitarella, D; Yeh, LT | 1 |
| Lin, CC; Philips, L; Xu, C; Yeh, LT | 1 |
| Bray, M; Endy, TP; Paragas, J; Whitehouse, CA | 1 |
| Lin, CC; Lourenco, D; Xu, G; Yeh, LT | 1 |
| Hong, Z; Larson, G; Wu, JZ | 1 |
| Dadgostari, S; Lin, CC; Vitarella, D; Xu, C; Yeh, LT | 1 |
| Bailey, KW; Sidwell, RW; Smee, DF; Wandersee, MK; Wong, MH | 1 |
| Aora, S; Gish, R; Lau, D; Lin, CC; Peterson, J; Rossi, S; Teng, A; Xu, C; Yeh, LT | 1 |
| Hong, Z; Larson, G; Shim, JH; Walker, H; Wu, JZ | 1 |
| Avci, A; Erhardt, A; Häussinger, D; Heintges, T; Lörke, J | 1 |
| Bailey, KW; Barnard, DL; Sidwell, RW; Smee, DF; Wong, MH | 1 |
| Forestier, N; Friedrich-Rust, M; Zeuzem, S | 1 |
| Lim, C; Lin, CC; Liu, Y; Xu, C; Yan, R; Yeh, LT | 1 |
| Chang, J; Gudima, S; Nie, X; Taylor, J | 1 |
| Hong, Z; Lin, CC; Wu, JZ; Yeh, LT | 1 |
| Stadlbauer, V; Stauber, RE | 1 |
| Longo, DL; Manns, MP; McHutchison, JG | 1 |
| Lin, CC; Xu, C; Yeh, LT; Zhu, N | 1 |
| Bu, W; Dadgostari, S; Lin, CC; Nguyen, M; Yeh, LT | 1 |
| Schiff, ER | 1 |
| Jacobson, I; Sigal, S | 1 |
| Brown, RS; Manns, MP; McHutchison, JG; Reddy, KR; Shiffman, ML; Wong, JB | 1 |
| Iino, S | 1 |
| Arora, S; Gish, RG; Murphy, B; Nelson, DR; O'Brien, C; Rajender Reddy, K; Xu, Y | 1 |
| Benhamou, Y | 1 |
| Kearney, KR; Navarro, VJ; Thornton, JJ | 1 |
| Afdhal, NH; Benhamou, Y; Chun, E; Halliman, DG; Heise, J; Nelson, DR; Pockros, PJ; Shiffman, ML | 1 |
| Pockros, PJ; Shields, WW | 1 |
| Chun, E; Gish, RG; Gitlin, N; Halliman, DG; Heise, J; Marcellin, P; Rodriguez-Torres, M | 1 |
| Samuel, D | 1 |
| Singh, V; Somvanshi, P | 1 |
| Bacon, BR; Chun, E; Halliman, D; Hammond, J; Hassanein, T; Heise, J; Lawitz, E; Muir, AJ; Poordad, F; Shiffman, ML | 1 |
| Kwo, PY; Vinayek, R | 1 |
| Cielecka-Kuszyk, J; Godzik, P; Komorowski, M; Madaliński, K | 1 |
| Arora, S; Deming, P | 1 |
| Palmer, M; Rubin, R; Rustgi, V | 1 |
| Brochot, E; Capron, D; Castelain, S; Duchaussoy, I; Duverlie, G; François, C; Helle, F; Nguyen-Khac, E; Van Nhien, AN | 1 |
| Abd-Rabou, AA; Bharali, DJ; Mousa, SA | 2 |
11 review(s) available for ribavirin and taribavirin
| Article | Year |
|---|---|
Prospects for hepatitis C virus therapeutics: levovirin and viramidine as improved derivatives of ribavirin.
Topics: Antiviral Agents; Hepatitis C; Humans; Ribavirin; Stereoisomerism | 2002 |
Viramidine (Ribapharm).
Topics: Animals; Clinical Trials as Topic; Hepatitis C; Humans; Ribavirin; Technology, Pharmaceutical | 2002 |
Ribavirin, viramidine and adenosine-deaminase-catalysed drug activation: implication for nucleoside prodrug design.
Topics: Adenosine Deaminase; Animals; Catalysis; Drug Design; Humans; Nucleosides; Prodrugs; Ribavirin | 2003 |
[Current treatment of hepatitis C virus infection].
Topics: Acute Disease; Amantadine; Animals; Antiviral Agents; Hepacivirus; Hepatitis B; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Polyethylene Glycols; Protease Inhibitors; Recombinant Proteins; Recurrence; Ribavirin; Transaminases; Treatment Failure; Viral Envelope Proteins; Viral Hepatitis Vaccines | 2005 |
Novel approaches for therapy of chronic hepatitis C.
Topics: Antidepressive Agents; Antiviral Agents; Clinical Trials as Topic; Erythropoietin; Genome, Viral; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Protease Inhibitors; Purine-Nucleoside Phosphorylase; Pyrimidine Nucleosides; Ribavirin; Viral Hepatitis Vaccines | 2006 |
Definition and management of anemia in patients infected with hepatitis C virus.
Topics: Anemia; Antiviral Agents; Cardiovascular System; Cognition Disorders; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hemoglobins; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin | 2006 |
Emerging strategies for pegylated interferon combination therapy.
Topics: Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Nucleic Acid Synthesis Inhibitors; Polyethylene Glycols; Protease Inhibitors; Recombinant Proteins; Ribavirin; Viral Vaccines; Virus Replication | 2007 |
Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy.
Topics: Anemia; Antiviral Agents; Drug Therapy, Combination; Erythropoietin; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Quality of Life; Recombinant Proteins; Ribavirin | 2007 |
[Drugs for hepatitis B and C infection].
Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Lamivudine; Mutation; Oligopeptides; Organophosphonates; Proline; Ribavirin; Serine Proteinase Inhibitors | 2007 |
Taribavirin for the treatment of chronic hepatitis C.
Topics: Anemia; Animals; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Hepatitis C, Chronic; Humans; Prodrugs; Ribavirin; Treatment Outcome | 2008 |
Taribavirin in the treatment of hepatitis C.
Topics: Anemia, Hemolytic; Antiviral Agents; Female; Hepacivirus; Hepatitis C; Humans; Male; Prodrugs; Ribavirin | 2011 |
7 trial(s) available for ribavirin and taribavirin
| Article | Year |
|---|---|
Pharmacokinetics and safety of viramidine, a prodrug of ribavirin, in healthy volunteers.
Topics: Administration, Oral; Adult; Antiviral Agents; Area Under Curve; Capsules; Chromatography, High Pressure Liquid; Dietary Fats; Dose-Response Relationship, Drug; Double-Blind Method; Food-Drug Interactions; Half-Life; Humans; Male; Mass Spectrometry; Middle Aged; Prodrugs; Ribavirin; Time Factors | 2004 |
Ascending multiple-dose pharmacokinetics of viramidine, a prodrug of ribavirin, in adult subjects with compensated hepatitis C infection.
Topics: Administration, Oral; Adult; Antiviral Agents; Erythrocytes; Female; Hepatitis C; Humans; Male; Middle Aged; Prodrugs; Ribavirin | 2005 |
Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study.
Topics: Adult; Aged; Anemia; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Thrombocytopenia; Treatment Outcome | 2007 |
A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 results.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2009 |
Safety and efficacy of viramidine versus ribavirin in ViSER2: randomized, double-blind study in therapy-naive hepatitis C patients.
Topics: Adult; Anemia; Antiviral Agents; Diarrhea; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Endpoint Determination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome | 2010 |
Virologic response rates of weight-based taribavirin versus ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C.
Topics: Adolescent; Adult; Anemia, Hemolytic; Antiviral Agents; Body Weight; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load | 2010 |
Randomised clinical trial: pre-dosing with taribavirin before starting pegylated interferon vs. standard combination regimen in treatment-naïve patients with chronic hepatitis C genotype 1.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Purine-Nucleoside Phosphorylase; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load | 2012 |
33 other study(ies) available for ribavirin and taribavirin
| Article | Year |
|---|---|
Analysis of the in vitro antiviral activity of certain ribonucleosides against parainfluenza virus using a novel computer aided receptor modeling procedure.
Topics: Antiviral Agents; Binding Sites; Chemical Phenomena; Chemistry; Chemistry, Physical; Computer Simulation; Drug Design; Models, Chemical; Models, Molecular; Molecular Conformation; Molecular Structure; Parainfluenza Virus 3, Human; Receptors, Virus; Respirovirus; Ribonucleosides; Structure-Activity Relationship | 1989 |
Synthesis and antiviral evaluation of N-carboxamidine-substituted analogues of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine hydrochloride.
Topics: Animals; Antiviral Agents; Bunyaviridae Infections; HIV-1; Mice; Molecular Structure; Ribavirin; RNA Viruses; Structure-Activity Relationship | 1992 |
Synthesis and antitumor activity of ribavirin imidates. A new facile synthesis of ribavirin amidine (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine hydrochloride).
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Friend murine leukemia virus; Humans; Leukemia L1210; Leukemia, Erythroblastic, Acute; Mice; Ribavirin; Ribonucleosides; Tumor Cells, Cultured | 1989 |
Effects of ribamidine, a 3-carboxamidine derivative of ribavirin, on experimentally induced Phlebovirus infections.
Topics: Administration, Oral; Animals; Antiviral Agents; Bunyaviridae; Bunyaviridae Infections; Cell Line; Female; Injections, Subcutaneous; Mice; Mice, Inbred C57BL; Molecular Structure; Ribavirin; Ribonucleosides; Specific Pathogen-Free Organisms | 1988 |
An in vivo and in vitro evaluation of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine: an inhibitor of human lymphoblast purine nucleoside phosphorylase.
Topics: Adenosine Kinase; Cell Line; Formycins; Humans; Hypoxanthine Phosphoribosyltransferase; IMP Dehydrogenase; Inosine; Lymphocytes; Pentosyltransferases; Purine-Nucleoside Phosphorylase; Ribavirin; Ribonucleosides | 1980 |
Treatment of lethal Pichinde virus infections in weanling LVG/Lak hamsters with ribavirin, ribamidine, selenazofurin, and ampligen.
Topics: Animals; Antiviral Agents; Arenaviruses, New World; Cricetinae; Female; Hemorrhagic Fever, American; Organoselenium Compounds; Poly I-C; Poly U; Ribavirin; Ribonucleosides; Specific Pathogen-Free Organisms; Survival Analysis; Tissue Distribution; Vero Cells; Weaning | 1993 |
Conformations of nucleoside analogue 1-(2'-deoxy-beta-D-ribofuranosyl)-1,2,4-triazole-3-carboxamide in different DNA sequence contexts.
Topics: Amides; Base Pairing; Circular Dichroism; Glycosides; Hydrogen Bonding; Nuclear Magnetic Resonance, Biomolecular; Nucleic Acid Conformation; Nucleic Acid Heteroduplexes; Oligodeoxyribonucleotides; Phosphorus Isotopes; Protons; Ribavirin; Sequence Analysis, DNA; Temperature; Thermodynamics | 2001 |
Activation and deactivation of a broad-spectrum antiviral drug by a single enzyme: adenosine deaminase catalyzes two consecutive deamination reactions.
Topics: Adenosine Deaminase; Deamination; Hydrogen-Ion Concentration; Prodrugs; Ribavirin; Substrate Specificity | 2003 |
Pharmacokinetics and metabolism of [14C]viramidine in rats and cynomolgus monkeys.
Topics: Administration, Oral; Animals; Antiviral Agents; Area Under Curve; Biotransformation; Chromatography, High Pressure Liquid; Feces; Half-Life; Injections, Intravenous; Intestinal Absorption; Macaca fascicularis; Male; Mass Spectrometry; Prodrugs; Rats; Rats, Sprague-Dawley; Ribavirin; Species Specificity | 2003 |
Viramidine, a prodrug of ribavirin, shows better liver-targeting properties and safety profiles than ribavirin in animals.
Topics: Administration, Oral; Animals; Antiviral Agents; Carbon Radioisotopes; Drug Delivery Systems; Erythrocytes; Haplorhini; Liver; Prodrugs; Rats; Ribavirin; Species Specificity; Tissue Distribution; Tritium | 2003 |
A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus.
Topics: Animals; Antiviral Agents; Azauridine; Cell Line; Chlorocebus aethiops; Coloring Agents; Cricetinae; Fibroblasts; Hemorrhagic Fever Virus, Crimean-Congo; Humans; Microbial Sensitivity Tests; Neutral Red; Organoselenium Compounds; Ribavirin; Ribonucleosides; Staining and Labeling; Vero Cells; Viral Plaque Assay; Virus Replication | 2004 |
Disposition and metabolic profiles of [14C]viramidine and [14C]ribavirin in rat and monkey red blood cells and liver.
Topics: Animals; Antiviral Agents; Area Under Curve; Biotransformation; Chromatography, DEAE-Cellulose; Erythrocytes; Liver; Macaca fascicularis; Male; Rats; Rats, Sprague-Dawley; Ribavirin | 2004 |
Dual-action mechanism of viramidine functioning as a prodrug and as a catabolic inhibitor for ribavirin.
Topics: Antiviral Agents; Chromatography, Thin Layer; Humans; In Vitro Techniques; Kinetics; Phosphorylases; Prodrugs; Ribavirin | 2004 |
Viramidine demonstrates better safety than ribavirin in monkeys but not rats.
Topics: Animals; Antiviral Agents; Area Under Curve; Blood Cell Count; Body Temperature; Body Weight; Eating; Electrocardiography; Eye Diseases; Female; Hemodynamics; Macaca fascicularis; Male; Organ Size; Rats; Rats, Sprague-Dawley; Respiratory Mechanics; Ribavirin | 2004 |
Treatment of mannan-enhanced influenza B virus infections in mice with oseltamivir, ribavirin and viramidine.
Topics: Acetamides; Administration, Oral; Animals; Antiviral Agents; Dose-Response Relationship, Drug; Hong Kong; Influenza B virus; Lung; Mannans; Mice; Organ Size; Orthomyxoviridae Infections; Oseltamivir; Ribavirin; Survival Rate | 2004 |
Phosphorylation of ribavirin and viramidine by adenosine kinase and cytosolic 5'-nucleotidase II: Implications for ribavirin metabolism in erythrocytes.
Topics: 5'-Nucleotidase; Adenosine Kinase; Animals; Antiviral Agents; Cricetinae; Cytosol; Erythrocytes; Humans; Kinetics; Phosphorylation; Ribavirin | 2005 |
In vitro and in vivo influenza virus-inhibitory effects of viramidine.
Topics: Administration, Oral; Animals; Antiviral Agents; Cell Line; Drug Evaluation, Preclinical; Female; Influenza A virus; Influenza B virus; Lethal Dose 50; Lung; Mice; Orthomyxoviridae Infections; Oximetry; Oxygen; Purine-Nucleoside Phosphorylase; Ribavirin | 2005 |
[Perspectives in hepatology in the next 2-3 years: what will be clinically relevant? Viral hepatitis].
Topics: Amantadine; Antiviral Agents; Genotype; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatovirus; Humans; Interferons; Nucleic Acid Synthesis Inhibitors; Protease Inhibitors; Ribavirin; Viral Load | 2005 |
Sensitive and specific LC-MS/MS method for the simultaneous measurements of viramidine and ribavirin in human plasma.
Topics: Antiviral Agents; Chromatography, High Pressure Liquid; Gas Chromatography-Mass Spectrometry; Humans; Reference Standards; Reference Values; Reproducibility of Results; Ribavirin; Sensitivity and Specificity | 2006 |
Action of inhibitors on accumulation of processed hepatitis delta virus RNAs.
Topics: Amanitins; Antiviral Agents; Cell Line; Dactinomycin; Dichlororibofuranosylbenzimidazole; Dose-Response Relationship, Drug; Genome, Viral; Hepatitis Delta Virus; Humans; Mycophenolic Acid; Polyadenylation; Ribavirin; RNA, Messenger; RNA, Viral; Virus Replication | 2006 |
Conversion of viramidine to ribavirin in vivo by adenosine deaminase and its inhibition by 2'-deoxycoformycin.
Topics: Adenosine Deaminase; Adenosine Deaminase Inhibitors; Animals; Antiviral Agents; Area Under Curve; Enzyme Inhibitors; Gas Chromatography-Mass Spectrometry; Male; Pentostatin; Prodrugs; Rats; Rats, Sprague-Dawley; Ribavirin | 2006 |
Absorption, metabolism, and excretion of [14C]viramidine in humans.
Topics: Absorption; Administration, Oral; Area Under Curve; Carbon Radioisotopes; Erythrocytes; Feces; Humans; Male; Middle Aged; Purine-Nucleoside Phosphorylase; Ribavirin | 2006 |
LC-MS/MS method for simultaneous determination of viramidine and ribavirin levels in monkey red blood cells.
Topics: Animals; Antiviral Agents; Calibration; Chromatography, High Pressure Liquid; Cytidine; Erythrocytes; Female; Haplorhini; Male; Mass Spectrometry; Quality Control; Reproducibility of Results; Ribavirin | 2007 |
Future therapies for hepatitis C: where do we go from here?
Topics: Antiviral Agents; Biomedical Research; Drug Design; Hepatitis C; Humans; Oligopeptides; Pyrimidine Nucleosides; Recombinant Fusion Proteins; Ribavirin; Toll-Like Receptors | 2007 |
Anemia and clinical outcomes in hepatitis C.
Topics: Anemia; Antiviral Agents; Drug Therapy, Combination; Hepatitis C; Humans; Ribavirin; Treatment Outcome | 2007 |
Ribavirin analogs.
Topics: Anemia, Hemolytic; Antiviral Agents; Carbamates; Hepacivirus; Hepatitis C; Humans; IMP Dehydrogenase; Mycophenolic Acid; Phenylurea Compounds; Ribavirin | 2009 |
Focus.
Topics: Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Drug Delivery Systems; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Humans; Liver Neoplasms; Ribavirin; Treatment Outcome | 2010 |
Structural modeling of the NS 3 helicase of Tick-borne encephalitis virus and their virtual screening of potent drugs using molecular docking.
Topics: Amino Acid Sequence; Antiviral Agents; Chemistry, Pharmaceutical; Computer Simulation; DNA Helicases; Drug Evaluation, Preclinical; Encephalitis Viruses, Tick-Borne; Genome, Viral; Molecular Conformation; Molecular Sequence Data; Monosaccharides; Ribavirin; RNA Helicases; RNA, Viral; Serine Endopeptidases; Software; Triazoles; Viral Nonstructural Proteins | 2009 |
The next step for taribavirin.
Topics: Anemia, Hemolytic; Antiviral Agents; Hepatitis C, Chronic; Humans; Ribavirin | 2010 |
[Inhibitors of hepatitis C virus--current standards and status of investigations].
Topics: Antiviral Agents; Clinical Trials as Topic; Drugs, Investigational; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2010 |
A new tool to study ribavirin-induced haemolysis.
Topics: Adenosine Triphosphate; Adult; Anemia, Hemolytic; Dipyridamole; Drug Evaluation, Preclinical; Drug Therapy, Combination; Erythrocytes; Glutathione; Hematologic Tests; Hemolysis; Hepacivirus; Hepatitis C, Chronic; Humans; Inhibitory Concentration 50; Interferon alpha-2; Interferon-alpha; Poliovirus; Polyethylene Glycols; Prodrugs; Recombinant Proteins; Ribavirin; RNA, Viral | 2012 |
Taribavirin and 5-Fluorouracil-Loaded Pegylated-Lipid Nanoparticle Synthesis, p38 Docking, and Antiproliferative Effects on MCF-7 Breast Cancer.
Topics: Antineoplastic Agents; Biological Availability; Breast Neoplasms; Drug Carriers; Drug Compounding; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Inhibitory Concentration 50; Lipids; MCF-7 Cells; Mitogen-Activated Protein Kinase 14; Molecular Docking Simulation; Nanoparticles; Polyethylene Glycols; Ribavirin | 2018 |
Viramidine-Loaded Galactosylated Nanoparticles Induce Hepatic Cancer Cell Apoptosis and Inhibit Angiogenesis.
Topics: Angiogenesis Inhibitors; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; MCF-7 Cells; Nanoparticles; Neovascularization, Pathologic; Ribavirin | 2020 |